尿生化指标对原发性骨质疏松症治疗的评价  

Urine biochemical indicators of the treatment of primary osteoporosis evaluation

作　　者：王秀袖[1] 

机构地区：[1]四川省广元市第一人民医院检验科,628017

出　　处：《中外妇儿健康（学术版）》2011年第2期1-3,共3页

摘　　要：目的:探讨尿生化指标吡啶酚(PYD)和脱氧吡啶酚(DPD)检测原发性骨质疏松症的疗效的价值。方法:回顾性分析我院2009年6月至2010年6月收治的60例原发性骨质疏松症患者的临床资料,该组患者于治疗测定前后分别测定PYD、DPD、尿钙(Ca)及尿羟脯氨酸(HOP)的浓度。结果:该组患者治疗后PYD/Cr、DPD/Cr与治疗前呈显著性差异,P<0.05;Ca/Cr、HOP/Cr与治疗前无显著性差异,P>0.05。结论:PYD、DPD可作为原发性骨质疏松症的良好评价指标,其不受饮食的影响,其不受摄食的影响。Objective：to explore the urine biochemical PYD paracetamol（pyridine and deoxypyridinoline（DPD） detecting primary osteoporosis curative value.Methods a retrospective study was June 2009—2010 June were 60 cases of patients with primary osteoporosis,this group of patients in clinical data were measured before and after treatment were PYD,DPD,urine calcium（Ca） and urine hydroxyproline（HOP） concentrations. Results this group of patients after treatment PYD/Cr,DPD/Cr and treatment before a significant difference（P0.05,Ca/Cr,HOP/Cr before treatment with no significant difference（P0.05）.Conclusion PYD,DPD primary osteoporosis can be used as the good evaluation index, the influence of the diet,not by ingestion of influence.

关 键 词：尿吡啶酚 尿脱氧吡啶酚 治疗 评价 

分 类 号：R446.12[医药卫生—诊断学]